Junchao Qian

Junchao Qian


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2025 in Advanced Science
Verified
Journal Article
Open access
PJPeiwei Jin
Peiwei Jin
DWDandan Wang
Dandan Wang
YLYijun Lu
Yijun Lu
YQYong Qian
Yong Qian
CFChengyang Fang
Chengyang Fang
HWHui Wang
Hui Wang
Single‐atom nanozymes (SAzymes) with low coordination structure has more active sites at an atomic level, which is one of the effective strategies to improve the efficiency of tumor catalytic therapy. Herein, it is reported that simple preparation of single‐atom manganese‐doped carbon dots (SA Mn‐CDs) with low coordination (Mn‐N2) configuration formed by chelating manganese atoms with ethylenediamine tetraacetic acid (EDTA). SA Mn‐CDs show good dispersibility of different solvents, excellent biological safety and stability, and show deep level (34 µm) of two‐photon fluorescence imaging ability and exclusive function (Pearson's correlation coefficient: 0.752) of targeting lysosomes at the cellular level. This further promotes the high‐efficiency peroxidase (POD)‐like activity (SA = 0.64 U mg−1) produced by the Fenton‐like reaction mediated by SA Mn‐CDs and shows excellent ability to kill tumor cells and shrink tumor tissues in vitro and in vivo respectively. This work proves the great potential of SA Mn‐CDs nanozyme in near‐infrared fluorescence‐guided tumor catalytic therapy.

30 April 2022 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
JQJunchao Qian
Junchao Qian
YSYoujiao Si
Youjiao Si
KZKe Zhou
Ke Zhou
YTYu Tian
Yu Tian
QGQisen Guo
Qisen Guo
JYJinming Yu
Jinming Yu
Background: This study aimed to determine the prognostic value of the sarcopenia on the progression free survival (PFS) and overall survival (OS) of esophageal squamous cell cancer (ESCC) patients who received radiotherapy (RT) or chemoradiotherapy (CRT). Methods: Data on clinicopathological characteristics and nutritional parameters were analyzed and correlated with PFS and OS, retrospectively. Skeletal muscle, subcutaneous, visceral and total fat tissue cross-sectional areas were evaluated on CT images at the midpoint of the 3rd lumbar vertebrae. A total of 213 patients were enrolled in this study. Results: Sarcopenia was significantly associated with subcutaneous fat content. The univariate analysis demonstrated that OS was superior in patients with non-sarcopenia, non-alcohol, NRI ≥ 100, albumin ≥ 40 g/L, TATI > 83.0, SATI > 27.8, VATI > 49, non-anemia, cervical and upper-thoracic ESCC, T stage 1–2, N stage 0–1 and TNM stage I–II. In the multivariate analysis, sarcopenia, albumin, N stage and TNM stage were identified as independent prognostic factors of survival. This study demonstrated that sarcopenia was related to worse PFS and OS in patients with ESCC who received RT or CRT. Conclusions: Sarcopenia is considered to be a useful predictor in patients with ESCC who received RT or CRT. This study also provided a conceptual basis for further prospective research on the application of the sarcopenia for patients receiving RT or CRT for intermediate- and advanced-stage ESCC.

6 April 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
YLYijun Lu
Yijun Lu
CZChen Zhou
Chen Zhou
JLJie Li
Jie Li
LLLingling Liu
Lingling Liu
XLXinyu Liu
Xinyu Liu
JQJunchao Qian
Junchao Qian

6 January 2023 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
YZYa’nAn Zhang
Ya’nAn Zhang
LLLu Liu
Lu Liu
WLWenling Li
Wenling Li
CZCaiyun Zhang
Caiyun Zhang
TSTianwei Song
Tianwei Song
GZGuilong Zhang
Guilong Zhang
As one of the most significant imaging modalities currently available, magnetic resonance imaging (MRI) has been extensively utilized for clinically accurate cancer diagnosis. However, low signal-to-noise ratio (SNR) and low specificity for tumors continue to pose significant challenges. Inspired by the distance-dependent magnetic resonance tuning (MRET) phenomenon, the tumor microenvironment (TME)-activated off–on T1–T2 dual-mode MRI nanoswitch is presented in the current study to realize the sensitive early diagnosis of tumors. The tumor-specific nanoswitch is designed and manufactured on the basis of PDGFB-conjugating ferroferric oxide coated by Mn-doped silica (PDGFB-FMS), which can be degraded under the high-concentration GSH and low pH in TME to activate the T1–T2 dual-mode MRI signals. The tumor-specific off–on dual-mode MRI nanoswitch can significantly improve the SNR and is used successfully for the accurate diagnosis of early-stage tumors, particularly for orthotopic prostate cancer. In addition, the systemic delivery of the nanoswitch did not cause blood or tissue damage, and it can be excreted out of the body in a timely manner, demonstrating excellent biosafety. Overall, the strategy is a significant step in the direction of designing off–on dual-mode MRI nanoprobes to improve imaging accuracy, which opens up new avenues for the development of new MRI probes.

30 July 2021 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
JXJianmin Xiao
Jianmin Xiao
MYMiao Yan
Miao Yan
KZKe Zhou
Ke Zhou
HCHui Chen
Hui Chen
ZXZhaowei Xu
Zhaowei Xu
Zhengyan WuZhengyan Wu
Zhengyan Wu
The cell membrane is widely considered as a promising delivery nanocarrier due to its excellent properties. In this study, self-assembled Pseudomonas geniculate cell membranes were prepared with high yield as drug nanocarriers, and named BMMPs. BMMPs showed excellent biosafety, and could be more efficiently internalized by cancer cells than traditional red cell membrane nanocarriers, indicating that BMMPs could deliver more drug into cancer cells. Subsequently, the BMMPs were coated with nanoselenium (Se), and subsequently loaded with Mn2+ ions and doxorubicin (DOX) to fabricate a functional nanoplatform (BMMP-Mn2+/Se/DOX). Notably, in this nanoplatform, Se nanoparticles activated superoxide dismutase-1 (SOD-1) expression and subsequently up-regulated downstream H2O2 levels. Next, the released Mn2+ ions catalyzed H2O2 to highly toxic hydroxyl radicals (·OH), inducing mitochondrial damage. In addition, the BMMP-Mn2+/Se nanoplatform inhibited glutathione peroxidase 4 (GPX4) expression and further accelerated intracellular reactive oxygen species (ROS) generation. Notably, the BMMP-Mn2+/Se/DOX nanoplatform exhibited increased effectiveness in inducing cancer cell death through mitochondrial and nuclear targeting dual-mode therapeutic pathways and showed negligible toxicity to normal organs. Therefore, this nanoplatform may represent a promising drug delivery system for achieving a safe, effective, and accurate cancer therapeutic plan.

25 October 2022 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
WXWenteng Xie
Wenteng Xie
YGYuehao Gan
Yuehao Gan
YZYa’nAn Zhang
Ya’nAn Zhang
PWPeng Wang
Peng Wang
JZJia Zhang
Jia Zhang
Zhengyan WuZhengyan Wu
Zhengyan Wu
This work clearly illustrated the mechanism of contrast enhancement in transition-metal-doped IONs, and it provides a novel paradigm for developing highly efficient T2 contrast agents.